CARDINAL HEALTH — Tetracycline Importer Profile
Pharmaceutical Importer · #3 buyer for Tetracycline · $1.2M import value · 42 shipments · UNITED STATES · DGFT Verified
CARDINAL HEALTH is the #3 importer of Tetracycline from India with $1.2M in import value and 42 verified shipments. CARDINAL HEALTH holds a 9.1% market share in Tetracycline imports based in UNITED STATES. The company sources from 2 verified suppliers across 13 formulations shipped to 1 country. Overall, CARDINAL HEALTH imports 5 pharmaceutical products worth $10.0M across 4 therapeutic categories.
CARDINAL HEALTH — Tetracycline Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Tetracycline to CARDINAL HEALTH?
Verified from 42 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| COHANCE LIFESCIENCES LIMITED | $980.2K | 36 | 81.5% |
| RA CHEM PHARMA LIMITED | $221.8K | 6 | 18.5% |
CARDINAL HEALTH sources Tetracycline from 2 verified Indian suppliers based on 42 customs records. The primary supplier is COHANCE LIFESCIENCES LIMITED accounting for 81.5% of imports.
How Does CARDINAL HEALTH Compare to Nearest Tetracycline Importers?
Buyers ranked immediately above and below #3 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | STE PRINCE PHARMA SARL | CONGO DR | $1.8M | 72 | $25.3K |
| 3 | CARDINAL HEALTH ★ | UNITED STATES | $1.5M | 39 | $39.6K |
| 1 | HEKO PHARMACY LTD | TANZANIA | $400.0K | 8 | $50.0K |
| 7 | PRINCE FARMA LDA, | ANGOLA | $251.9K | 7 | $36.0K |
CARDINAL HEALTH ranks #3 among 660 Tetracycline importers from India. Average shipment value of $39.6K compared to the market average of $8.6K. The closest competitors by value are STE PRINCE PHARMA SARL and HEKO PHARMACY LTD.
Where Does CARDINAL HEALTH Import Tetracycline To?
Destination countries from 42 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $1.2M | 42 | 100.0% |
CARDINAL HEALTH imports Tetracycline to 1 country. The primary destination is UNITED STATES receiving 100.0% of shipments worth $1.2M.
What Tetracycline Formulations Does CARDINAL HEALTH Import?
| Formulation | Value | Shipments |
|---|---|---|
| TETRACYCLINE HYDROCHLORIDE CAPSULES USP | $357.2K | 9 |
| TETRACYCLINE HYDROCHLORIDE CAPSULES, USP | $221.8K | 6 |
| TETRACYCLINE HYDROCHLORIDE CAPSULES USP500MG (100S COUNT)NOS | $198.7K | 13 |
| TETRACYCLINE HYDROCHLORIDE CAPSULES USP500MG 100S COUNT | $72.5K | 2 |
| TETRACYCLINE HYDROCHLORIDE CAPSULES USP500MG (100 S) | $71.5K | 2 |
| TETRACYCLINE HYDROCHLORIDE CAPSULES USP500 MG (100S) | $53.6K | 2 |
| TETRACYCLINE HYDROCHLORIDE CAPSULES USP500 MG (4305X100S) | $50.0K | 1 |
| Tetracycline Hydrochloride Capsules USP500mg 100 s 17232 x 100 numbers | $50.0K | 1 |
| TETRACYCLINE HYDROCHLORIDE CAPSULES USP500 MG (2439 X 100) | $30.9K | 1 |
| TETRACYCLINE HYDROCHLORIDE CAPSULES USP250MG 100S COUNT | $24.6K | 1 |
CARDINAL HEALTH imports 13 distinct Tetracycline formulations from India. The top formulation is TETRACYCLINE HYDROCHLORIDE CAPSULES USP with 9 shipments worth $357.2K.
Regulatory Requirements: Importing Tetracycline into United States
What CARDINAL HEALTH and other importers must comply with to import Tetracycline from India
Regulatory Authority
U.S. Food and Drug Administration (FDA)
Approval Process for Generic Tetracycline
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10–18 months for ANDA approval
GMP Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
Import Licence & Documentation
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
Labeling & Packaging
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Tetracycline from India and How Much Does CARDINAL HEALTH Import?
India exported $5.7M worth of Tetracycline through 2,829 shipments from 263 suppliers to 128 countries, serving 660 buyers globally. CARDINAL HEALTH imports $1.2M of this total, accounting for 9.1% of India's Tetracycline exports with 42 shipments from UNITED STATES. This is verified from 42 customs shipment records covering 13 distinct formulations.
What Is the Average Order Value for CARDINAL HEALTH's Tetracycline Imports?
CARDINAL HEALTH's average Tetracycline order value is $28.6K per consignment, based on 42 shipments totaling $1.2M. CARDINAL HEALTH is based in UNITED STATES and ranks #3 among all Tetracycline importers from India by value. The company sources from 2 verified suppliers in India.
Who Supplies Tetracycline to CARDINAL HEALTH?
CARDINAL HEALTH sources Tetracycline from 2 verified Indian suppliers: COHANCE LIFESCIENCES LIMITED ($980.2K, 81.5%), RA CHEM PHARMA LIMITED ($221.8K, 18.5%). This is based on 42 customs records.
How Does CARDINAL HEALTH Compare to Other Tetracycline Importers?
CARDINAL HEALTH ranks #3 among 660 Tetracycline importers from India with a 9.1% market share. The top 3 importers are STE PRINCE PHARMA SARL ($1.8M), CARDINAL HEALTH ($1.5M), HEKO PHARMACY LTD ($400.0K). CARDINAL HEALTH processed 42 shipments from UNITED STATES.
What Other Antibiotics Products Does CARDINAL HEALTH Import?
CARDINAL HEALTH also imports these antibiotics products. Each links to the detailed product page.
About CARDINAL HEALTH
CARDINAL HEALTH imports 5 products worth $10.0M. Beyond Tetracycline, top products include Clindamycin, Diclofenac, Exemestane, Alprazolam. View the complete CARDINAL HEALTH profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Tetracycline — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Tetracycline shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: CARDINAL HEALTH matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as CARDINAL HEALTH's capped import value divided by total capped export value for Tetracycline across all Indian exporters.
- 5.Verified Records: This page is backed by 42 individual customs records matching CARDINAL HEALTH importing Tetracycline, covering 13 formulations from 2 verified suppliers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 128+ countries, 660+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Tetracycline Import Data for CARDINAL HEALTH
Access order-level details, pricing data, supplier connections, and competitive analysis for CARDINAL HEALTH's Tetracycline imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
CARDINAL HEALTH
Full Company Profile →
5 products · $10.0M total trade · 4 categories
CARDINAL HEALTH × Tetracycline
Verified from customs records
Company Overview
Top Products by CARDINAL HEALTH
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for CARDINAL HEALTH.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Tetracycline. For current order-level data, contact TransData Nexus.